$7.290
-0.069 (-0.95%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
KZR Prediction & Forecast by Similar Chart Analysis
Alphio's KZR stock price prediction model matches the current Kezar Life Sciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.31 (+0.24%). The 1-week path is $7.44 (+2.07%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Kezar Life Sciences Inc Stock?
Kezar Life Sciences Inc (KZR) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The lack of significant trading signals, neutral trading trends, weak financial performance, and no recent positive news or catalysts make this stock less appealing for immediate investment. Holding or exploring other opportunities may be more prudent.
KZR stock price ended at $7.29 on Friday, after losing -0.95%
Kezar Life Sciences Inc (KZR) last closed at $7.29, losing -0.95%. These facts feed the 1-day and 1-week KZR price prediction above.
Analyst Consensus
Kezar Life Sciences Inc (KZR): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Kezar Life Sciences Inc (KZR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches KZR, ranked by similarity.
Seasonality analysis for KZR
Historically the probability of a positive August return for KZR is 0.00%. March offers the highest probability of a positive month at 46.03%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.